Tarsus Pharmaceuticals
TARS
TARS
41 hedge funds and large institutions have $410M invested in Tarsus Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
8% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 12
22% less capital invested
Capital invested by funds: $523M → $410M (-$113M)
Holders
41
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$934K | |
| 2 | +$680K | |
| 3 | +$560K | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
+$456K |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
+$397K |
Top Sellers
| 1 | -$1.91M | |
| 2 | -$827K | |
| 3 | -$409K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$276K |
| 5 |
Morgan Stanley
New York
|
-$263K |